An Open-Label, Dose-Escalation, Phase I/II Study to Inve

  • Moertel, Christopher (PI)

Project: Research project

Project Details

Description

An Open-Label, Dose-Escalation, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the MEK Inhibitor Trametinib in Children and Adolescents Subjects with Cancer
StatusActive
Effective start/end date9/19/146/30/21

Funding

  • GlaxoSmithKline

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.